Browsing Tag
Dr Jay Mei
1 post
Antengene receives approval for ATG-016 clinical trial in myelodysplastic syndrome
Antengene, a leading Chinese biopharmaceutical company, has announced a significant milestone with the approval of its Phase 1/2…